title: Sphingosine-1-Phosphate and Its Receptors: A Mutual Link between Blood Coagulation and Inflammation.
abstract: Sphingosine-1-phosphate (S1P) is a versatile lipid signaling molecule and key regulator in vascular inflammation. S1P is secreted by platelets, monocytes, and vascular endothelial and smooth muscle cells. It binds specifically to a family of G-protein-coupled receptors, S1P receptors 1 to 5, resulting in downstream signaling and numerous cellular effects. S1P modulates cell proliferation and migration, and mediates proinflammatory responses and apoptosis. In the vascular barrier, S1P regulates permeability and endothelial reactions and recruitment of monocytes and may modulate atherosclerosis. Only recently has S1P emerged as a critical mediator which directly links the coagulation factor system to vascular inflammation. The multifunctional proteases thrombin and FXa regulate local S1P availability and interact with S1P signaling at multiple levels in various vascular cell types. Differential expression patterns and intracellular signaling pathways of each receptor enable S1P to exert its widespread functions. Although a vast amount of information is available about the functions of S1P and its receptors in the regulation of physiological and pathophysiological conditions, S1P-mediated mechanisms in the vasculature remain to be elucidated. This review summarizes recent findings regarding the role of S1P and its receptors in vascular wall and blood cells, which link the coagulation system to inflammatory responses in the vasculature.
authors.affiliation: Institut für Pharmakologie, Universitätsmedizin Greifswald, Felix-Hausdorf Strasse 3, 17487 Greifswald, Germany.
authors.forename: Shailaja
authors.initials: S
authors.lastname: Mahajan-Thakur
authors.affiliation: Institut für Pharmakologie, Universitätsmedizin Greifswald, Felix-Hausdorf Strasse 3, 17487 Greifswald, Germany.
authors.forename: Andreas
authors.initials: A
authors.lastname: Böhm
authors.affiliation: Institut für Pharmakologie, Universitätsmedizin Greifswald, Felix-Hausdorf Strasse 3, 17487 Greifswald, Germany.
authors.forename: Gabriele
authors.initials: G
authors.lastname: Jedlitschky
authors.affiliation: Institut für Pharmakologie und Klinische Pharmakologie, Universitätsklinikum Düsseldorf, Universitätsstrasse 1, 40225 Düsseldorf, Germany.
authors.forename: Karsten
authors.initials: K
authors.lastname: Schrör
authors.affiliation: Institut für Pharmakologie, Universitätsmedizin Greifswald, Felix-Hausdorf Strasse 3, 17487 Greifswald, Germany.
authors.forename: Bernhard H
authors.initials: BH
authors.lastname: Rauch
mesh_terms: D001777:Blood Coagulation / Q000276:immunology / Q000502:physiology*; D001808:Blood Vessels / Q000502:physiology; D004730:Endothelium, Vascular / Q000502:physiology; D006801:Humans; D007249:Inflammation / Q000097:blood* / Q000276:immunology*; D008246:Lysophospholipids / Q000097:blood* / Q000276:immunology*; D008955:Models, Cardiovascular; D018448:Models, Immunological; D015539:Platelet Activation; D049349:Receptors, Lysosphingolipid / Q000097:blood* / Q000276:immunology*; D018179:Receptors, Thrombin / Q000378:metabolism; D015398:Signal Transduction; D013110:Sphingosine / Q000031:analogs & derivatives* / Q000097:blood / Q000276:immunology
chemical_list: D008246:Lysophospholipids; D049349:Receptors, Lysosphingolipid; D018179:Receptors, Thrombin; C060506:sphingosine 1-phosphate; D013110:Sphingosine